News About: Pharm. Industry
SK Chemical/Pharm announce Korean launch of frovatripan.
SK Chemical and SK Pharm said on October 3 that they signed an exclusive agreement with UK-based Vernalis Co. for the distribution of anti-migraine drug Migard (frovatriptan succinate) in Korea, noting that the launch...
Yungjin Pharm to market HEXAL’s Amlocard tablet
Yungjin Pharm said on October 4 it has obtained exclusive marketing and distribution rights to HEXAL’s Amlocard (amlodipine besylate) tablet for the treatment of hypertension in Korea.
Amlocard tablet, which was ap...
MSD Korea announced urgent recall of Vioxx.
MSD Korea instructed all physicians about an urgent recall of Vioxx via a phone or fax including official letters far aggressively for a prompt withdrawal of the stocks from the market place except wholesalers where p...
Court approves normalized management of Yungjin Pharm
The Seoul District Court on October 4 gave the green light to the normalized operation of Yungjin Pharm.
With the court approval, the management of Yungjin, which has been under court receivership since 1997, w...
Pharmaceutical stocks likely pick up in coming quarters
Pharmaceutical stocks will likely get a boost in the coming quarters on their defensive nature and expectations for visible outcomes of R&D new drug projects, bolstered by potential sales of generics over Novarsc and ...
Green Cross Sang-A and PBM merged under Green Cross.
Green Cross Sang-A will be renamed to Green Cross corporation in the shareholder's meeting on Oct. 4 after the merger of Green Cross PBM on Sept. 30.
Now, Green Cross Holdings will stand as a stock holding company...
Lilly Korea launches Cialis campaign
Lilly Korea said it has launched its Cialis campaign, urging patients with erectile dysfunction to take the drug before finishing their daily work.
For health care providers, pharmacists and ED patients this campai...
International conference of pharmaceutical medicine to hold in Sept. 2006
The Seoul international conference of pharmaceutical medicine (ICPM2006) will open in Seoul Korea for the first time in Asia in Sept. 2006.
Mr. Lee Dong-ho, the chief organizing commissioner of ICPM2006 took part i...
Court approves normalized management of Yungjin Pharm
The Seoul District Court on October 4 gave the green light to the normalized operation of Yungjin Pharm.
With the court approval, the management of Yungjin, which has been under court receivership since 1997, w...
Merck & Co. announces voluntary withdrawal of Vioxx from worldwide market
Merck &. Co., Inc. on September 30 announced a voluntary worldwide withdrawal of Vioxx (rofecoxib), its arthritis and acute pain medication. The company's decision, which is effective immediately, is based on new, thr...
